Eos SENOLYTIX Detailed MitoXcel Research in Berlin
The Houston-based firm will present preclinical data on its geropeptide candidate as it approaches a Q4 2026 merger.
Live Poll
Do you trust that pharmaceutical mergers typically lead to better treatment options for patients?